Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption

NCT02371473 is registered in ClinicalTrials.gov with Shahid Beheshti University of Medical Sciences as lead sponsor.

NCT NCT02371473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02371473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption
Lead sponsor
Shahid Beheshti University of Medical Sciences
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2014
Completion date
December 31, 2018
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central sleep apnea, secondary